AI Insight
A large international clinical trial led by University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM) has demonstrated that an AI-based tool can effectively automate and optimize radiotherapy treatment planning for both cervical cancer and prostate cancer. The technology showed sufficient accuracy and reliability to support clinical decision-making in radiotherapy delivery. These findings suggest that AI-assisted planning could be deployed across diverse healthcare settings, including resource-limited environments where cervical cancer burden is highest.
Why it matters
Cervical cancer disproportionately affects women in low- and middle-income countries where access to specialized radiotherapy planning expertise is limited, and an AI tool capable of streamlining this process could significantly expand treatment capacity and contribute to global cervical cancer elimination efforts.
An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM).
Source: AI tool for radiotherapy can support the global effort to eliminate cervical cancer